Investors Buy Large Volume of Amedisys Put Options (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) was the target of some unusual options trading on Friday. Stock investors purchased 3,269 put options on the stock. This is an increase of approximately 136% compared to the average daily volume of 1,385 put options.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Innealta Capital LLC acquired a new stake in shares of Amedisys during the 2nd quarter valued at about $64,000. Signaturefd LLC boosted its position in Amedisys by 88.2% during the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after purchasing an additional 530 shares in the last quarter. Commonwealth Equity Services LLC increased its position in shares of Amedisys by 10.9% in the second quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock valued at $381,000 after buying an additional 409 shares in the last quarter. Versor Investments LP raised its stake in shares of Amedisys by 23.5% during the 2nd quarter. Versor Investments LP now owns 6,721 shares of the health services provider’s stock worth $617,000 after buying an additional 1,279 shares during the period. Finally, Privium Fund Management UK Ltd purchased a new position in shares of Amedisys during the 2nd quarter valued at approximately $1,284,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Up 4.7 %

Shares of AMED opened at $89.96 on Friday. The company has a market capitalization of $2.95 billion, a price-to-earnings ratio of 35.70, a PEG ratio of 1.84 and a beta of 0.73. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The stock’s 50-day moving average price is $90.45 and its 200-day moving average price is $94.43. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.98 EPS. On average, sell-side analysts predict that Amedisys will post 4.45 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.